A Pilot Trial of Two-Fraction Stereotactic Body Radiation Therapy for Localized Prostate Cancer
Two-fraction ultra-hypofractionated radiation to 25 Gy is tolerable with a low rate of long-term toxicity and promising biochemical control. Further research is indicated to evaluate two-fraction regimens for prostate radiation.
Authors
- Jay Shiao (ORCID: https://orcid.org/0000-0002-4926-8820)
- M. Chen
- Ying Cao
- Leah Miller
- Xinglei Shen
- Amanda Schroeder
Institutions
- University of Kansas Medical Center (US)
Publication Details
- Journal
- Cureus
- Published
- 2025-12-31
- DOI
- https://doi.org/10.7759/cureus.100519
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00